Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapy
Lizhen
He
a,
Yanyu
Huang
a,
Yanzhou
Chang
a,
Yuanyuan
You
a,
Hao
Hu
a,
Kam W.
Leong
*b and
Tianfeng
Chen
*a
aDepartment of Chemistry, Jinan University, Guangzhou, 510632, China. E-mail: tchentf@jnu.edu.cn
bDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA. E-mail: kwl2121@columbia.edu
First published on 22nd June 2020
Abstract
Correction for ‘A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapy’ by Lizhen He et al., J. Mater. Chem. B, 2017, 5, 8228–8237, DOI: 10.1039/C7TB02163A.
The authors regret that incorrect images were used in Fig. 1d and h (electron microscopic images and N 1s spectrum of RGD@Se-MSNs) and Fig. 7c (H&E staining images of major organs from HepG-2 xenograft nude mice) in the original version of the manuscript. The corrected Fig. 1 and 7 are shown below. The captions remain the same.
 | ||
| Fig. 1 Rational design (a), delivery (b) and action mechanisms (c) of RGD@Se-MSNs nanosystem for dual targeting and therapy of tumor growth and angiogenesis. (d) SEM and TEM micrographs of RGD@Se-MSNs. (e) N2 adsorption–desorption isotherm of MSNs and RGD@Se-MSNs. XPS analysis (f), O 1s (g) and N 1s (h) spectra of SeC, MSNs and RGD@Se-MSNs. | ||
 | ||
| Fig. 7 (a) Selenium content in plasma versus time after intravenous injection of free SeC and RGD@Se-MSNs. (b) Biodistribution of Se in tumor tissue and main organs of the xenograft nude mice treated with 1 mg kg−1 RGD@Se-MSNs for 14 days. (c) H&E staining of major organs from HepG-2 xenograft nude mice treated with 1 mg kg−1 (calculated as Se) of RGD@Se-MSNs for 14 days. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2020 |